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TITLE OF CASE 'RQRWLQFOXGH³DFDVHUHSRUW´ 
Auto-inflammatory constrictive pericarditis and chronic myelomonocytic leukaemia (CMML). 
When one speciality is not enough. 
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
We present a case of constrictive pericarditis with concomitant blood and bone marrow 
appearances of chronic myelomonocytic leukaemia (CMML). Despite surgical treatment with 
pericardiectomy, the patient deteriorated into multi-organ failure. Pericardial histology disclosed 
a typical-inflammatory picture with no evidence of monocytic or malignant infiltrate. Following 
intensive collaboration between cardiologists, haematologists and rheumatologists via daily email 
exchanges, a diagnosis was reached of autoinflammatory constrictive pericarditis with a non-
infiltrative coexisting CMML. The key to achieving a rapid and sustained response was a trial of 
high dose steroids followed by intravenous immunoglobulins (IVIG). This achieved restoration of 
cardiac function, resolution of symptoms and near normalisation of inflammatory markers. A 
diagnosis of concurrent CMML was confirmed at 3 months. The patient remains well, taking 
colchicine and steroids. 
BACKGROUND Why you think this case is important ± why did you write it up? 
Less than one fifth of cases of pericarditis present with a specific aetiology.[1] This patient did 
not present typically for constriction; nor did he meet the criteria for acute or chronic 
myelomonocytic leukaemia.[Table 1][2] Weight loss and lack of response to standard treatment 
suggested there was likely to be a pathogenic underlying aetiology. Successful diagnosis and 
treatment was only achieved with daily cross-speciality input from haematology, cardiology and 
rheumatology. Consideration of early trial of high dose steroids in addition to combination 
therapies including a novel use of intravenous immunoglobulins (IVIG) led to complete recovery. 
This case highlights the need for rapid and decisive liaison between specialists (in this case via 
hospital email to minimise delays) in complex cases of acute constrictive auto-inflammatory 
pericarditis. 
 
CASE PRESENTATION Presenting features, medical/social/family history 
An active, Caucasian male in his late 70s presented with a six week history of 10kg weight loss 
and epigastric pain radiating to the back. There was no dyspnoea, fever, sweating or recent 
illness. His past medical history included a left trigeminal nerve Schwannoma two years 
previously (successfully treated with gamma knife irradiation), peptic ulcer disease and 
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hypertension. He was an ex-smoker with no significant alcohol or recreational drug history. On 
examination, vital signs were within normal range, he had a raised jugular venous pulse, basal 
crepitations and a pericardial friction rub. There was no palpable lymphadenopathy or 
hepatosplenomegaly.  The ECG revealed left bundle branch block, widespread concave ST 
segment elevation and left axis deviation. 
 
INVESTIGATIONS If relevant 
Chest radiography revealed clear lung fields with cardiomegaly. An echocardiogram showed 
moderate to severely impaired left ventricular function with an akinetic, thinned lateral 
myocardium and a thickened pericardium causing likely constriction but no effusion.[Fig 1.] 
Computed chest tomography confirmed a thickened pericardium.[Fig 2.] A coronary angiogram 
was performed which demonstrated normal coronary arteries making Dressler¶s syndrome 
unlikely though coronary embolus could not be entirely excluded.  Full blood count revealed: Hb 
103 (131-166), Plt 126 (150-400) and WBC 17.5 (3.5-9.5), monocytosis 8.75 (0.25-1.0) which 
was morphologically consistent with CMML but did not meet diagnostic criteria.[Table 1][2] 
Serum C-reactive protein level was 232 (<5) and Ferritin 812 (30-400). Serial High Sensitivity 
Troponin-T (HSTnT) were 25, 24, 27 (<14). A complete Viral PCR was performed from 
respiratory, stool and serological samples. This included: Human Immunodeficiency Virus (HIV), 
Hepatitis B and C, Ebstein Barr Virus (EBV), Cytomegalovirus (CMV), Influenza A/B, 
Parinfluenza 1-4, Human Metapneumo-, Rhino-, Corona-, Entero and Adenoviruses, Human 
Herpes Virus-6 (HHV6) and HHV7. The results were all negative. Bone marrow biopsy was  
morphologically consistent with CMML-1,[Fig 3] however the monocytosis has not yet persisted 
over 3 months and reactive monoclonal causes had not yet been excluded at the time.[Table 1][2] 
Immunophenotyping showed no increase in CD34+ myeloid blast cells with a mature monocytic 
component, expressing CD14 at 22%. Cytogenetics showed normal male karyotype. FISH 
analysis of 100 interphase nuclei has shown no evidence of BCR-ABL1 rearrangement nor 
evidence of Platelet Derived Growth Factor Receptor (PDGFR-A, PDGFR-B) or Fibroblast 
Growth Factor Receptor (FGFR-1) rearrangement at chromosomes 4q12, 5q32 and 8p11, 
respectively (99% chance of detecting a 5% cell population), and JAK-2 mutation was not 
detected. High throughput and Sanger sequencing was requested for somatic myeloid mutation 
analysis. A diagnosis of pericarditis with constrictive features due to a reactive monocytosis was 
considered. It was unclear whether this was secondary to infiltration or inflammation.  
Table 1: Diagnostic criteria adapted from WHO (2016) CMML criteria.[2] 
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All FIVE of the following must be met: 
Peripheral Blood 3HUVLVWHQWPRQRF\WRVLVî9/L, with monocytes accounting 
IRURIWKH:%&FRXQW and <20% blasts 
Flourescence In Situ 
Hybridisation (FISH) analysis 
No evidence of PDGFR-A, PDGFR-B, or FGFR-1 
rearrangement or PCM1-JAK2 (to be specifically excluded if 
eosinophilia) 
Bone Marrow <20% blasts (including myeloblasts, monoblasts and 
promonocytes) 
Exclusions Not meeting WHO criteria for BCR-ABL1 CML, PMF, PV, or 
ET as cases of myeloproliferative neoplasms (MPN) can be 
associated with monocytosis and simulate CMML. Presence of 
these features in the bone marrow or MPN-associated 
mutations (JAK2, CALR, or MPL) tend to support alternative 
diagnosis of MPN with monocytosis  
Myelodysplasia Present in one or more myeloid lineages. However if absent or 
minimal and all other requirements are met can be diagnosed if 
an acquired clonal cytogenetic or molecular genetic 
abnormality is present  
Or the monocytosis has persisted for at least 3 months, and all 
other causes of monocytosis have been excluded (e.g. 
infection, inflammation, malignancy) 
Subcategories  
CMML-1 < 5 % blasts (promonocytes, monoblasts, myeloblasts) in the 
blood and < 10% blasts in the marrow 
CMML-2 5 ± 19% blasts in the blood, OR 10 ± 19% blasts in the 
marrow, OR presence of Auer rods 
 
 
DIFFERENTIAL DIAGNOSIS If relevant 
Initial presentation suggested dominant cardiac failure with constrictive pericarditis. Initial 
differentials considered myocardial aetiologies such as Takotsubo¶s cardiomyopathy or 
myocardial infarction however these were not explained by imaging or angiographic results. The 
aetiology of constrictive pericarditis in a previously fit, ex-smoking white male was unlikely to be 
tuberculosis (quantiferon gold testing was negative). There was no history of pre-existing auto-
immune disease and virology was negative. Weight loss and marked monocytosis raised the 
possibility of an infiltrative leukaemia, but cytogenetic testing of the bone marrow biopsy and 
cytological examination of the pleural aspirate were negative by formal criteria. Monocytic 
infiltration of the pericardium was therefore thought to be unlikely, but was not yet excluded. The 
main differential was therefore a reactive macrophage activation syndrome secondary to acute 
pericarditis of undetermined aetiology. Pericardiectomy offered the opportunity to provide 
therapeutic and diagnostic benefit. Surgical options considered were Video-Assisted Thorascopic 
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Surgery (VATS) offering a smaller incision and biopsy versus midline sternotomy and 
pericardiectomy. The key determinant in approach was whether constriction was present, 
requiring left and right heart catheterisation. 
 
TREATMENT If relevant  
Despite an adequate trial of colchicine, the patient¶VFRQGLWLRQZDVGHWHULRrating and serial CRP 
measurements remained high (150-300). By day 10 he worsened with cardiac, respiratory and 
renal failure and congestive liver injury. There was a pleural effusion, which was drained. Pleural 
fluid analysis revealed an exudate according WR/LJKW¶VFULWHULD.[3][4][5] Left and right heart 
catheterisation disclosed elevation of right sided pressures with equalisation of the diastolic 
pressure throughout all cardiac chambers. In order to treat deterioration and achieve definitive 
diagnosis, a pericardiectomy was performed via midline sternotomyat day 19. This failed to 
deliver clinical benefit or a definitive diagnosis, but did exclude neoplasia, TB and infiltration. 
Histology was consistent with a pattern typical of a non-specific inflammatory process. 
 
In the absence of infiltration, and with confirmation of an underlying inflammatory condition, 
prednisolone 60mg daily was commenced. This led to an improvement in CRP, but pleural 
effusions re-accumulated. The cardiac failure continued to be resistant to intravenous diuretics 
with no improvement in left ventricular function and the clinical picture deteriorated further.[Fig 
4] Empirical trial of high dose methylprednisolone led to improvement in inflammatory markers, 
blood count and heart failure parameters.  
 
This sustained improvement to high dose steroids suggested an inflammatory disorder either 
driven by, or driving, the monocytes, but cause and effect remained unclear. Further daily 
exchanges between the relevant specialties raised the possibility of an auto-inflammatory 
serositis. Treatment with IVIG was initiated.  With this regimen he showed a further marked 
improvement in symptoms, physical signs and organ function. The patient was discharged from 
hospital 14 days later (13 weeks after admission).  
 
OUTCOME AND FOLLOW-UP   
Four months later, he remains well and has resumed normal activities. Maintenance therapy 
comprises reducing doses of prednisolone and colchicine. Left ventricular function had 
completely recovered by 8 weeks.[Fig 5]  Follow-up over three months demonstrated persistence 
of the monocytosis despite resolution of his inflammatory disorder. High throughput and Sanger 
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sequencing also detected TET2, ASXL1 and SRSF2 mutations, thereby confirming clonality and 
a diagnosis of CMML-1.[Table 1][2] His current results show a CRP of 32 (<5), WCC 37.8 (3.5-
9.5) and monocyte count of 13.57 (0.25-1.0). No active treatment is required for his CMML.  The 
diagnostic conclusion drawn was a rare, life-threatening case of acute inflammatory carditis 
(involving both myocardium and pericardium). We conclude that this was triggered by underlying 
CMML.[6][7]  
 
DISCUSSION Include a very brief review of similar published cases  
This case was an unusual presentation of both CMML and pericarditis with few typical features 
of either condition. There was no evidence of leukaemic infiltration in the pericardial histology. 
There was little initial response in LV function to pericardiectomy, and no resolution of 
monocytosis or CRP to colchicine but an encouraging response to high dose steroids and a 
definitive response to IVIG. Multi-disciplinary input, with rapid and frequent discussion was vital 
for reaching a unifying diagnosis and achieving therapeutic success.  
 
Standard treatment for CMML varies depending on blood counts, severity of the bone marrow 
appearances, proliferative markers and corresponding prognostic scores.[8] Milder forms have a 
median life expectancy of greater than 8 years. These cases require µwatchful waiting¶ or µactive 
observation¶ in the outpatient setting with monitoring of full blood count parameters at regular 
intervals. Symptomatic treatment for common complications such as anaemia, infection or severe 
thrombocytopenia may be required. In this case, treatment was required for pericarditis. In cases 
of more advanced disease with high prognostic scores, active treatment options include 
hypomethylating agents, chemotherapy and allogenic stem cell transplantation. 
 
This case also highlights the need for careful consideration of the differential diagnoses in acute 
pericarditis. In Western Europe, most cases are idiopathic (78-86%), the remainder being 
neoplastic (5-7%), tuberculous (4%) and autoimmune or post-cardiac surgery (1-7%).[1] The 
subset progressing to constriction in developed countries are idiopathic (33-46%), post-radiation 
(9-31%), post-surgery (11-37%), post-infective (4-20%) or due to connective tissue disease (3-
7%).[1] Many undiagnosed aetiologies of carditis are likely to be viral in origin. These include, 
but not exclusively, HIV, EBV, CMV, influenza-, adeno-,  entero- and herpes-viruses. Aside from 
HIV, routine screening is not recommended as this rarely impacts on treatment and is not cost-
effective.[9] Pericarditis with a non-idiopathic aetiology are more likely to present with clinical 
markers such as high fever, subacute onset, large pericardial effusion, cardiac tamponade and lack 
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of response to aspirin or non-steroidal anti-inflammatory agent (NSAID).[1]  
 
European Society of Cardiology Guidelines,[1] for the management of pericarditis recommend 
NSAIDs with proton-pump inhibitor (PPI) cover as first line treatment. Most treatment failures in 
acute pericarditis are due to inadequate treatment doses or interruption in course of treatment.[1] 
Whilst colchicine can reduce the recurrence in acute pericarditis by about 50%, this generally 
fails in monotherapy. Efficacy has been demonstrated for combination therapy with NSAID and 
in poorly responsive cases, corticosteroids. Azathioprine is useful as a steroid-sparing agent. In 
recurrent acute episodes, both IVIG and an interleukin-1 receptor antagonist (Anakinra) are 
recommended. This case demonstrated the novel incorporation of a biological agent in quadruple 
therapy for a first, but life-threatening, presentation of acute carditis.  Guidelines advise 
continuation until complete resolution of symptoms and normalisation of the CRP are achieved.  
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points ± this is a required 
field 
x The presence of both pancarditis and monocytosis should prompt a unifying aetiology 
such as an autoinflammatory disorder.  
x Pericarditis presenting with a significant monocytosis should involve exclusion of 
malignant infiltration (haematological and non-haematological causes), infective, autoimmune 
and connective tissue diseases.   
x Early use of more aggressive treatments (e.g. IVIG/Anakinra) in cases of autoimmune 
pericarditis showing immediate response to high dose prednisolone should be considered. 
x Close multi-disciplinary input (daily email updates and discussions) may be required to 
effectively diagnose and treat complex cases such as this. 
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FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
Fig 1. Admission echocardiography showing moderate to severe left ventricular impairment   
Fig 2. Computed Tomography demonstrating thickened pericardium 
Fig 3.  Bone marrow aspirate appearance suggestive of CMML (x50) 
Fig 4.  Echocardiography pre- and post-pericardiectomy showing severe left ventricular 
impairment 
Fig 5.  Normal echocardiography 8 weeks post-discharge 
Fig 6.  
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